AR065795A1 - Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros. - Google Patents
Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros.Info
- Publication number
- AR065795A1 AR065795A1 ARP080101143A ARP080101143A AR065795A1 AR 065795 A1 AR065795 A1 AR 065795A1 AR P080101143 A ARP080101143 A AR P080101143A AR P080101143 A ARP080101143 A AR P080101143A AR 065795 A1 AR065795 A1 AR 065795A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- fluor
- alkyl
- alkoxy
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Estos compuestos son agonistas del HM74A y pueden emplearse como medicamentos. Reivindicacion 1: Compuestos de formula (1) en donde X1 es N o C(R6); X2 es N o C(R7); X3 es N o C(R8), en donde por lo menos uno de X1, X2 y X3 es N; Y es un enlacesencillo, O, N(R9)C(O), C(O)NR9, N(R9)C(O)O, OC(O)NR9, N(R9)C(O)NR10, N(R9)SO2 o SO2N(R9); Z es un enlace sencillo, o, si n es 1, 2, 3, 4, 5 o 6, Y puede también ser O; R1, R2, R3 y R4 independientemente entre si son hidrogeno, fluor, alquiloinferior o fluor-alquilo inferior, o R1 y R2 están unidos juntamente para formar un anillo juntamente con el átomo de carbono al cual están unidos y -R1-R2- es -(CH2)2-6-, o R3 y R4 están unidos juntamente para formar un anillo juntamente con elátomo de carbono al cual están unidos, y -R3-R4- es -(CH2)2-6-; R5 es arilo o heteroarilo, el cual arilo o heteroarilo está opcionalmente substituido con 1 a 3 sustituyentes independientemente seleccionados del grupo formado por halogeno, alquiloinferior, alcoxilo inferior, fluor-alquilo inferior, fluor-alcoxilo inferior, cicloalquilo, fluor-cicloalquilo, cicloalquil-oxilo, C(O)OH, alcoxilo inferior-C(O), NH2C(O), N(H,alquilo inferior)C(O), N(alquilo inferior)2C(O), OH, alquilo inferior-C(O)O, NH2, N(H, alquilo inferior), N(alquilo inferior)2, alquilo inferior-C(O)NH, alquilo inferior-C(O)N(alquilo inferior), NH2SO2, N(H, alquilo inferior)SO2, N(alquilo inferior)2SO2, alquilo inferior-SO2-NH, alquilo inferior-SO2-N(alquiloinferior), ciano y fenilo el cual está opcionalmente substituido con 1 a 3 substituyentes independientemente seleccionados del grupo formado por halogeno, alquilo inferior, alcoxilo inferior y fluor-alquilo inferior; R6 es hidrogeno, halogeno,alquilo inferior, fluor-alquilo inferior, alcoxilo inferior, fluor-alcoxilo inferior o cicloalquilo; R7 es hidrogeno, halogeno, alquilo inferior, fluor-alquilo inferior, alcoxilo inferior, fluor-alcoxilo inferior o cicloalquilo; R8 es hidrogeno,halogeno, alquilo inferior, fluor-alquilo inferior, alcoxilo inferior, fluor-alcoxilo inferior o cicloalquilo; R9 y R10 independientemente entre sí son hidrogeno, alquilo inferior o fluor-alquilo inferior; m es 0, 1, 2 o 3; n es 0, 1, 2, 3, 4, 5 o6; en donde m + n es >=1; con la condicion de que si X1 es CH, X2 es CH y X3 es N, m + n no es 1; y las sales y ésteres farmacéuticamente aceptables de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07104801 | 2007-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR065795A1 true AR065795A1 (es) | 2009-07-01 |
Family
ID=39473201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101143A AR065795A1 (es) | 2007-03-23 | 2008-03-19 | Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros. |
Country Status (15)
Country | Link |
---|---|
US (1) | US7928106B2 (es) |
EP (1) | EP2139895A1 (es) |
JP (1) | JP2010521513A (es) |
KR (1) | KR101115891B1 (es) |
CN (1) | CN101641358A (es) |
AR (1) | AR065795A1 (es) |
AU (1) | AU2008231873B2 (es) |
BR (1) | BRPI0808721A2 (es) |
CA (1) | CA2680775A1 (es) |
CL (1) | CL2008000806A1 (es) |
IL (1) | IL200618A0 (es) |
MX (1) | MX2009010218A (es) |
PE (1) | PE20090189A1 (es) |
TW (1) | TW200902532A (es) |
WO (1) | WO2008116742A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009097995A1 (de) * | 2008-02-07 | 2009-08-13 | Sanofi-Aventis | Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2010127208A1 (en) * | 2009-04-30 | 2010-11-04 | Forest Laboratories Holdings Limited | Inhibitors of acetyl-coa carboxylase |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2014085528A1 (en) | 2012-11-29 | 2014-06-05 | Merck Patent Gmbh | Azaquinazoline carboxamide derivatives |
US10882868B2 (en) | 2014-05-15 | 2021-01-05 | Hoffmann-La Roche Inc. | Compounds for treating spinal muscular atrophy |
JO3719B1 (ar) * | 2014-11-20 | 2021-01-31 | Takeda Pharmaceuticals Co | 4- أوكسو-4،3- داي هيدرو-3،2،1- بنزوترايازينات كمواد ضابطة لأجل gpr139 |
CN105616420A (zh) * | 2016-01-16 | 2016-06-01 | 赵国良 | 一种降血脂的药物组合物 |
CN105853737A (zh) * | 2016-05-17 | 2016-08-17 | 范信 | 一种治疗风湿、颈肩腰腿痛的药物 |
DK3728254T3 (da) | 2017-12-21 | 2023-06-06 | Boehringer Ingelheim Int | Benzylamin-substituerede pyridopyrimidinoner og derivater som sos1-inhibitorer |
CN108218861B (zh) * | 2018-02-05 | 2019-07-23 | 黑龙江中医药大学 | 一种预防和治疗糖尿病的药物及其制备方法 |
US20230180756A1 (en) | 2020-05-12 | 2023-06-15 | Bayer Aktiengesellschaft | Triazine and pyrimidine (thio)amides as fungicidal compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2378912A1 (fr) | 1977-01-26 | 1978-08-25 | Pollet Sa | Cloison amovible ou demontable et elements constitutifs de ladite cloison |
FR2645152B1 (fr) * | 1989-03-30 | 1991-05-31 | Lipha | 3h-pteridinones-4, procedes de preparation et medicaments les contenant |
ATE440825T1 (de) * | 2003-06-06 | 2009-09-15 | Vertex Pharma | Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern |
PT1781657E (pt) * | 2004-02-14 | 2013-05-23 | Glaxosmithkline Ip Dev Ltd | Medicamentos com actividade no receptor hm74a |
ES2389907T3 (es) * | 2004-04-30 | 2012-11-02 | Takeda Pharmaceutical Company Limited | Compuesto de amida heterocíclica y uso del mismo como un inhibidor de MMP-13 |
WO2006023381A1 (en) * | 2004-08-16 | 2006-03-02 | Taigen Biotechnology | Pyrimidinone compounds |
ITBO20050076A1 (it) | 2005-02-17 | 2006-08-18 | Metal Work Srl | Struttura per il supporto di elementi a definire una parete |
WO2006124490A2 (en) * | 2005-05-17 | 2006-11-23 | Schering Corporation | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
CA2651573C (en) | 2006-05-23 | 2011-12-06 | F. Hoffmann-La Roche Ag | Pyridopyrimidinone derivatives |
-
2008
- 2008-03-11 CA CA002680775A patent/CA2680775A1/en not_active Abandoned
- 2008-03-11 CN CN200880008341A patent/CN101641358A/zh active Pending
- 2008-03-11 WO PCT/EP2008/052846 patent/WO2008116742A1/en active Application Filing
- 2008-03-11 JP JP2009553996A patent/JP2010521513A/ja active Pending
- 2008-03-11 MX MX2009010218A patent/MX2009010218A/es active IP Right Grant
- 2008-03-11 EP EP08717593A patent/EP2139895A1/en not_active Withdrawn
- 2008-03-11 KR KR1020097019781A patent/KR101115891B1/ko not_active IP Right Cessation
- 2008-03-11 AU AU2008231873A patent/AU2008231873B2/en not_active Ceased
- 2008-03-11 BR BRPI0808721-0A patent/BRPI0808721A2/pt not_active IP Right Cessation
- 2008-03-17 US US12/049,460 patent/US7928106B2/en not_active Expired - Fee Related
- 2008-03-19 PE PE2008000510A patent/PE20090189A1/es not_active Application Discontinuation
- 2008-03-19 AR ARP080101143A patent/AR065795A1/es not_active Application Discontinuation
- 2008-03-20 TW TW097109941A patent/TW200902532A/zh unknown
- 2008-03-20 CL CL2008000806A patent/CL2008000806A1/es unknown
-
2009
- 2009-08-27 IL IL200618A patent/IL200618A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2009010218A (es) | 2009-10-19 |
BRPI0808721A2 (pt) | 2014-08-12 |
AU2008231873B2 (en) | 2011-11-10 |
KR20090122964A (ko) | 2009-12-01 |
US7928106B2 (en) | 2011-04-19 |
AU2008231873A1 (en) | 2008-10-02 |
PE20090189A1 (es) | 2009-03-12 |
IL200618A0 (en) | 2010-05-17 |
CL2008000806A1 (es) | 2008-11-07 |
EP2139895A1 (en) | 2010-01-06 |
CA2680775A1 (en) | 2008-10-02 |
JP2010521513A (ja) | 2010-06-24 |
TW200902532A (en) | 2009-01-16 |
US20080234277A1 (en) | 2008-09-25 |
WO2008116742A1 (en) | 2008-10-02 |
CN101641358A (zh) | 2010-02-03 |
KR101115891B1 (ko) | 2012-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR065795A1 (es) | Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros. | |
AR061058A1 (es) | Derivados de piridopirimidininona. procesos de obtencion y composiciones farmaceuticas | |
ES2422204T3 (es) | Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS) | |
CO6231035A2 (es) | Novedoso compuesto heteromonociclico que tiene propiedades superiores como agente farmaceutico | |
AR070437A1 (es) | Moduladores de beta - amiloide | |
AR076067A1 (es) | Composiciones y metodos para modular la senda de senalizacion de wnt | |
AR056560A1 (es) | Pirrolopiridinonas como moduladores cb1 | |
AR077440A1 (es) | Bencenosulfonamidas como bloqueadores de canales de calcio y composiciones farmaceuticas | |
AR058124A1 (es) | Derivados de ftalazinona como inhibidores de parp-1 | |
AR077695A1 (es) | Derivados de pirimidina como inhibidores del factor ixa | |
CO6321130A2 (es) | Piridinas carboxamidas como inhibidores de la 11 beta-hsd1 | |
CO5680412A2 (es) | Agonistas del receptor adrenergico etilamino beta 2 sustituido con amino | |
AR068538A1 (es) | Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido | |
AR082029A1 (es) | Derivados de heterociclos nitrogenados, composiciones y metodos para modular la via de señalizacion de wnt | |
AR056265A1 (es) | N-aminometilensulfonamidas sustituidas, su preparacion y su uso como medicamentos | |
PE20060620A1 (es) | Analogos de biaril piperazinil-piridina sustituidos como moduladores del receptor de capsaicina vr1 | |
AR069814A1 (es) | Derivados de 4 amino-pirimidina, proceso de preparacion y composiciones farmaceuticas que los contienen | |
AR069480A1 (es) | Derivados de 2-amino-pirimidina | |
PE20140968A1 (es) | Derivados de benzamida sustituida | |
AR048567A1 (es) | Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas. | |
AR051325A1 (es) | Analogos de biarilquinolin-4-ilamina sustituidos | |
CO5031250A1 (es) | Compuesto farmaceutico | |
AR069813A1 (es) | Derivados de 2- amino-pirimidina, una composicion farmaceutica, un metodo de preparacion del compuesto y uso del mismo para preparar un medicamento | |
CO5601021A2 (es) | Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb | |
AR052308A1 (es) | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |